SRW

SRW (Science Research Wellness) sells oral longevity supplements that target cellular repair, immune resilience, joint health, cognition, and skin. Single bottles run NZD 79–139 (≈ USD 50–90), placing the range in mid-to-premium territory; multi-unit “Cel” system bundles climb above NZD 300. All commerce is direct-to-consumer through the brand’s own site with global shipping; no brick-and-mortar stockists are listed. Formulations are built around patented or trademarked complexes—e.g., Cel1 with Hobamine 2-HOBA, Cel2 with NMN and CoQ10, Cel3 with spermidine and fisetin—each paired with peer-reviewed white papers downloadable from the product pages. The company positions itself as “cellular system maintenance,” translating academic aging research into three sequential daily capsules rather than the typical single-ingredient booster. Core buyers are 35-60-year-old professionals in Australasia and North America who track biomarkers, follow longevity podcasts, and want evidence-linked stacks without compounding raw powders themselves. The brand speaks in data (clinical graphs, scientist quotes) and promises “function now, resilience later,” aligning with quantified-self values more than generic wellness aspiration. SRW competes in the crowded anti-aging supplement space against single-molecule and broad-spectrum “longevity blends.” It differentiates by sequencing three complementary SKUs (Cel1-2-3) that mirror proposed hallmarks of aging, publishing open-access summaries for every active, and batch-testing in New Zealand–certified labs, giving consumers a transparent, protocol-ready stack rather than a kitchen-sink formula.